External Body Weight Effects on Body Weight in Adults With Grade II and III Obesity

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEscoles Universitaries Gimbernat

About this trial

Obesity is a growing problem in industrialized societies. This condition is associated with an increase in metabolic and cardiovascular diseases. Its cause is multifactorial, influenced by the environment, excessive calorie consumption, insufficient physical activity, sedentary lifestyle and alterations in energy metabolism.

In this context, the hormone leptin, responsible for regulating appetite and body weight, presents resistance in people with obesity, altering the metabolic balance. Recent research has explored the concept of the "gravitostat", a system that responds to the mechanical stimulus of standing upright, as a promising approach in the regulation of body weight. Animal and human studies have shown positive results in weight loss and body recomposition using this system. However, more research is needed to evaluate the clinical applicability and effectiveness of the gravitostat in the management of obesity.

For this reason, the present study is proposed, with a prospective longitudinal controlled design in the use of external body weight (where the patients are their own control: intrasubject controlled study) during 4 weeks, with a previous control period of 4 weeks and a follow-up of 4 weeks. The proposed objectives are to analyze the effectiveness of the use of external weight in the regulation of body weight, body composition and analytical parameters in people with grade II and III obesity. In this way, to analyze the clinical applicability of the gravitostat in the management of patients with this metabolic pathology.

Eligibility criteria

Qualifiers

Age>18 years

BMI (≥35)

Compliance at intervention delivery.

Disqualifiers

Chronic pathology that may hinder the performance of the intervention

Chronic pain

Regular consumption of pharmacology or supplementation that affects body weight

Inability to perform any physical activity or high risk of suffering adverse effects from the interventibariatric-metabolic surgery

Trial design

Treatments tested in this trial

  • Weighted vest

Treatment groups

24 Participants
are divided into 1 treatment group

Sponsors and collaborators

Escoles Universitaries Gimbernat

Lead sponsor

Corporacion Parc Tauli

Collaborator